Macroscopic small bowel mucosal injury caused by chronic nonsteroidal anti-inflammatory drugs (NSAID) use as assessed by capsule endoscopy

Revista Espanola de Enfermedades Digestivas

Volumn 102, Issue 2, 2010, Pages 80-85

  Caunedo Alvarez A ^a   Gomez Rodriguez B J ^a   Romero Vazquez J ^a   Arguelles Arias F ^a   Romero Castro, R ^a   Garcia Montes J M ^a   Pellicer Bautista, F J ^a   Herrerias Gutierrez J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Capsule endoscopy; Controlled; Enteropathy; Nsaid; Prospective; Small bowel mucosal injury

Indexed keywords

DEXIBUPROFEN; DICLOFENAC; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CAPSULE ENDOSCOPY; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROPATHY; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HUMAN; MALE; OSTEOARTHRITIS; RATING SCALE; STOMACH MUCOSA INJURY;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAPSULE ENDOSCOPY; CYCLOOXYGENASE 2 INHIBITORS; DICLOFENAC; DUODENAL DISEASES; DUODENAL ULCER; FEMALE; HUMANS; IBUPROFEN; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OSTEOARTHRITIS; PEPTIC ULCER HEMORRHAGE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; STOMACH DISEASES; STOMACH ULCER;

EID: 77951908777     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Cullen DJ, Seager JM, Holmes S, Doherty M, Wilson JV, Garrud P, et al. Pharmacoepidemiology of nonsteroidal anti-inflammatory drug use in Nottingham general practices. Aliment Pharmacol Ther 2000; 14: 177-85.
2. Anonymous. Retail and provider prospective: National prescription audit. Plymouth Meeting, PA, IMS Health; 2000.
3. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994, 330: 1287-94.
4. Husain SS, Szabo IL, Tarnawski AS. NSAID Inhibition of GI cancer growth: clinical implications and molecular mechanisms of action. Am J Gastroenterol 2002; 97: 542-53.
5. Straus WL, Ofman JJ. Gastrointestinal toxicity associated with nonsteroidal anti-inflammatory drugs: epidemiologic and economic issues. Gastroenterol Clin N Am 2001; 30: 895-920.
6. Lanas A. Cost stratification of nonsteroidal anti-inflammatory drug-associated gastrointestinal side effects. Med Clin (Barc) 2000; 114(Supl. 3): 46-53.
7. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993; 104: 1832-47.
8. Fortun PJ, Hawkey CJ. Nonsteroidal anti-inflammatory drugs and the small intestine. Curr Opin Gastroenterol 2005; 21: 169-75.
9. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated the use of non-steroidal anti-inflammatory drugs. N Engl J Med 1992; 327: 749-54.
10. Kwo PY, Tremaine WJ. Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature. Mayo Clin Proc 1995; 70: 55-61.
11. Lang J, Price AB, Levi AJ, Burke M, Gumpel JM, Bjarnason I. Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol 1988; 41: 516-26.
12. Morris AJ, Madhok R, Sturrok RD, Capell HA, MacKenzie JF. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet 1991; 337: 520-4.
13. Hayat M, Axon ATR, O'Mahony S. Diagnostic yield and effect on clinical outcomes of push enteroscopy in suspected small-bowel bleeding. Endoscopy 2000; 32: 369-72.
14. Pennazio M, Santucci R, Rondonotti E, Abbiati C, Beccari G, Rossini FP, et al. Clinical outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: report of 100 consecutive cases. Gastroenterology 2004; 126: 643-53.
15. Herrerías JM, Caunedo A, Rodríguez Téllez M, Pellicer FJ, Herrerías JM Jr. Capsule endoscopy in patients with suspected Crohńs disease in negative endoscopy. Endoscopy 2003; 35: 564-9.
16. Bowel disorders detection system approved. FDA news daily bulletin July 11, 2003. Available at: www.fdanews.com/dailies/bulletin/1_134/news/15318-1.html. Accessed September 7, 2005
17. Iddan G, Meron G, Glukhovsky A, Swain P. Wireless capsule endoscopy. Nature 2000; 405: 417.
18. Bjarnason I, Fehilly B, Smethurst P, Menzies IS, Levi AJ. Effects of nonsteroidal antiinflammatory drugs on permeability of the small intestine in humans. J Rheumatol 1992; 19(Supl. 36): 83-4.
19. Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhold MK, Roseth A, et al. High prevalence of NSAID enteropathy as shown by a simple fecal faecal test. Gut 1999; 45: 362-6.
20. Morris AJ, Wasson LA, Mackenzie JF. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 1992; 33: 887-9.
21. Velayos B, Muñoz MF, Fernández L, Aller R, Lozano F, de la Calle F, et al. Measurement of lesion size by capsule endoscopy: an unsolved issue. Rev Esp Enferm Dig 2008; 100: 248-9.
22. Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastro-enterol Hepatol 2005; 3: 55-9.
23. Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005; 128: 1172-8.
24. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazol and placebo. Clin Gastro-enterol Hepatol 2005; 3: 133-41.